Literature DB >> 34032001

Supraphysiological estradiol promotes human T follicular helper cell differentiation and favours humoural immunity during in vitro fertilization.

Cong Hu1,2, HongLei Liu3, Bo Pang1,4, Hao Wu5, Xiuying Lin6, Yu Zhen7,8, Huanfa Yi1,8.   

Abstract

During pregnancy, humoural immunity is essential for protection against many extracellular pathogens; however, autoimmune diseases may be induced or aggravated. T follicular helper (Tfh) cells contribute to humoural immunity. The aim of this study was to test whether Tfh cell function can be manipulated via hormones. Seventy-four women who underwent in vitro fertilization were recruited and divided into four groups: menstrual period (MP), controlled ovarian hyperstimulation (COH), embryo transfer (ET) and pregnant after embryo transfer (P). A flow cytometry analysis was performed to identify Tfh cells in peripheral blood mononuclear cells (PBMCs). Bioinformatics analysis revealed a possible pathway between Tfh and B cells. Enzyme-linked immunosorbent assays were used to detect interleukin (IL)-21 and IL-6. The quantitative polymerase chain reaction was performed to quantify BCL-6, BACH2, XBP-1, IRF-4 and G protein-coupled (GP)ER-1 mRNA expression. Compared with the MP group, the COH, ET and P groups showed more Tfh and B cells, as well as higher IL-21, IL-6, BCL-6 and BACH2 expression. Furthermore, Tfh cell frequency in PBMCs, as well as serum IL-21 and IL-6 levels, were all positively correlated with serum estradiol (E2 ) levels; the B cell percentage also correlated positively with Tfh cells in PBMCs. Combined with the bioinformatics analysis, XBP-1, IRF-4 and GPER-1 expression was related to E2 levels, both in vivo and in vitro. We speculate that E2 augments Tfh cells and favours humoural immunity. This study indicates that Tfh cell regulation may be a novel target in maintaining the maternal-foetal immune balance.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  B cells; T follicular helper cells; estradiol; humoural immunity; in vitro fertilization

Mesh:

Substances:

Year:  2021        PMID: 34032001      PMCID: PMC8278094          DOI: 10.1111/jcmm.16651

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


INTRODUCTION

Pregnancy is characterized by high levels of both oestrogen and progesterone in vivo. , , Changes in these hormones during pregnancy appear to inhibit the cellular immune response classically mediated by T helper (Th)1/Th2 and Th17/T regulatory cells , and, in contrast, increase antibody production by memory B lymphocytes. It has been reported that in some Th1‐driven autoimmune diseases, pregnancy can temporarily abate the clinical signs in the mother. , Humoural immunity is essential for protection against extracellular pathogens; however, excess autoantibody production during pregnancy may induce or aggravate autoimmune diseases such as rheumatic antiphospholipid syndrome and systemic lupus erythematosus. , , The mechanism underlying the relationship between maternal hormones and humoural immunity remains unclear. T follicular helper (Tfh) cells are a unique subset of CD4+ T cells that play important roles in germinal centre (GC) formation and high‐affinity antibody generation. , Tfh cells and GC B cells share some transcriptional networks, and many molecular pathways regulating Tfh cells can be deduced from B cells. Tfh cells, first observed in human lymphoid tissues, are characterized by IL‐21 and IL‐6 release and the expression of some unique molecules and factors, such as CD4, B cell lymphoma 6 (BCL6), inducible co‐stimulatory molecule (ICOS), CXC chemokine receptor 5 (CXCR5) and programmed death‐1 (PD‐1). Thus, Tfh cells are defined as CD4+BCL6+ICOS+CXCR5+ PD‐1+. BCL6 is the master transcriptional factor for the development of both GC B cells and Tfh cells induced by IL‐6, , , whereas CXCR5 is induced by IL‐21 and ICOS. , In addition, BCL6 is necessary for early CXCR5 expression. , , As a subset that facilitates T cell‐dependent B cell activation, Tfh cells play important roles in autoreactive B cell proliferation, promoting the production of autoantibodies. During pregnancy, Tfh cell numbers increase in both mice and human beings and decrease in case of a miscarriage. , When PD‐1 or IL‐21 are blocked, spontaneous abortion is high in mice as a consequence. , Estradiol (E2) is the predominant hormone in females that plays pivotal roles in endocrine and reproductive systems. E2 also manipulates immune cells in autoimmune diseases and exacerbates some cancers. , In mice, E2 treatment decreases the Tfh cell response and suppresses Bcl6 and Il‐21 mRNA expression to control autoantibody production; however, the effect of E2 on Tfh cells in humans is still obscure. Controlled ovarian hyperstimulation (COH) with supraphysiological E2 and without a progesterone antagonist is an approach to assist in vitro fertilization (IVF). It can be used to explore the relationship between E2 and Tfh cells, B cells and immunity in human beings. In this study, we aimed to observe and identify the relationship between Tfh and B cell numbers, and E2 levels, during IVF. We also determined the levels of IL‐6, IL‐21, BCL6 and BACH2, and their correlation with E2 levels.

MATERIAL AND METHODS

Patients’ samples

Women of an average age of 30.23 ± 3.06 years, undergoing IVF treatment (n = 74), were recruited from March to October 2019 at the Reproductive Medicine Center of Jilin Province People's Hospital (Supplementary Table S1). The inclusion criteria were as follows: (i) first IVF cycle, (ii) less than 35 years old, (iii) good ovarian response, (iv) normal karyotype and hormones and (v) without uterine abnormalities (fibroid, uterine septum, and uterine polyp), endometriosis or any other known immunological diseases. Luteal‐phase GnRH‐a protocol was performed in all patients. GnRH‐a (Triptorelin Acetate Injection) was used to suppress pituitary, then, recombinant follicle‐stimulating hormone (Gonal‐F) and human menopausal gonadotropin (menotrophins for injection) were used for ovarian stimulation. When the dominant follicles (three or more) reached 18 mm in diameter, human chorionic gonadotrophin for injection (HCG) was administered. Transvaginal ultrasound‐guided oocyte retrieval was performed 36 hours later. Luteal phase support was performed using 90 mg of vaginal progesterone (Crinone gel 8%), administered from the oocyte retrieval day. Three‐day later, two high‐quality embryos were transferred into an adequately prepared endometrium. Early pregnancy was defined as the presence of an intrauterine gestational sac, with positive β‐hCG results 4 weeks later. Luteal phase support was continued until 9 weeks gestation (almost 7 weeks after embryo transfer). Patients were divided into four groups according to the stage of IVF treatment, menstrual period (MP), n = 20; controlled ovarian hyperstimulation (COH), n = 25; embryo transfer (ET), n = 15; and pregnant after embryo transfer (P), n = 14. The MP group was the basic hormone group with low E2 and progesterone; the COH group had hyperphysiological E2 levels without progesterone; the ET group had high E2 and progesterone levels (progesterone is an antagonist of E2); and the P group had higher E2 and progesterone levels.

Blood mononuclear cells isolation and flow cytometry

Blood from peripheral and cord vein was collected in sterile heparinized tubes from each patient. Peripheral blood mononuclear cells (PBMC) and cord blood mononuclear cells (CBMC) were obtained by Ficoll‐Hypaque gradient centrifugation, and analysed by flow cytometry. Fixable viability dye Efluor780 (FVD) was used to discriminate dead cells. The following anti‐human fluorescence conjugated antibodies and their corresponding isotype controls used were as follows: anti‐human CD4‐APC (clone OKT4, Biolegend), FVD (BD), anti‐human CXCR5‐PE (clone J252D4, Biolegend), anti‐human PD‐1‐FITC (clone A17188B, Biolegend) and anti‐human CD19‐Percpcy5.5 (clone 4G7, Biolegend). Cells were washed with cold PBS for three times, and resuspended in fluorescence activating cell sorter flow buffer (PBS containing 0.1% BSA and 0.04% EDTA‐Na2) to a density of 1 × 106 cells/mL and then incubated for 15 minutes at room temperature in the dark place with 2 μL fluorochrome‐conjugated Abs. Tfh cells were defined as CD4+CXCR5+PD‐1+ and B cells as CD19+. Data were analysed with FlowJo 10.0 software package (Treestar Inc).

Magnetic beads separation

Naïve CD4+ T Cell Isolation Kit II (Miltenyi Biotec) was used to isolate naïve CD4+ T cells from CBMC. Briefly, determined cell number and viability (>99%) by Trypan blue staining. Then, resuspend cell pellet in 40 μL of buffer, added 10 μL of biotin‐antibody cocktail per 107 total cells and incubated for 5 minutes in 4°C. Added 20 μL of buffer and 20 μL of anti‐biotin microbeads per 107 total cells. Added 10 μL of CD44 microbeads per 107 total cells and incubated for 10 minutes in 4°C. Finally, naïve CD4+ T cells were sorted (purity >95%, viability >99%) by column in the magnetic field of a suitable magnetic activating cell separator.

Cell culture

Naïve CD4+ T cells were suspended in RPMI 1640 medium (Gibco) supplemented with 2 mM L‐glutamine, 10 mM HEPES, 20 mM 2‐methoxyestradiol, 150 U/mL streptomycin, 200 U/mL penicillin and 10% foetal bovine serum. Then, naïve CD4+ T cells (2 × 105) were transferred into 96‐well plates, which were plate bound with 5 μg/mL anti‐human CD3 purified antibody (OKT3, eBioscience) overnight in 4°C conditions. Treated with 1 μg/mL anti‐human CD28 purified antibody (CD28.2, eBioscience), 5 ng/mL Recombinant Human TGF‐β1 Protein (R&D), 10 ng/mL Recombinant Human IL‐23 Protein (R&D), 10 ng/mL Recombinant Human IL‐6 (R&D), 0‐20 μM E2 (Sigma‐Aldrich). The cultures were maintained at 37°C in a 5% CO2‐humidified atmosphere. Medium was changed on the third day. The proportion of CD4+CXCR5+PD‐1+ Tfh cells were analysed by flow cytometry on the sixth day.

Enzyme‐linked immunosorbent assays (ELISA)

Serum samples collected from patients were kept at −80°C. Enzyme immunoassays were performed to determine the concentration of IL‐21 and IL‐6 using ELISA kits (Biolegend). Human serum was diluted 1:1 in sample buffer and incubated for 30 minutes. Following three washes with the washing buffer, the bound antibodies were detected by incubation with anti‐human IgG HRP conjugate for 30 minutes. Then, the samples were washed again as described earlier, and tetramethyl benzidine substrate was added for 15 minutes. The optical density was read at 450 nm using an automated spectrophotometer. All samples were assayed in duplicate.

Quantitative real‐time polymerase chain reaction (qRT‐PCR)

Initially, total RNA was extracted from PBMC using AxyPrep Multisource Total RNA Miniprep Kit (Axygen). The RNA quality was checked based on the A260/A280 ratio, and pure RNA samples were converted to cDNA using PrimeScript RT Reagent Kit with gDNA Eraser in accordance with the manufacturer's instructions (Takara Bio). The polymerase chain reaction was performed using SYBR Green based on the instruction manual (Takara Bio). The primer sequences are presented in Table 1 (Comate Bioscience). The relative mRNA expression of different genes was quantified using the ∆∆C method. Β‐actin was used as a housekeeping gene.
TABLE 1

Oligonucleotide and primer sequence

OligonucleotidePrimer sequence
β‐actin

5′‐TTCAACACCCCAGCCATG‐3′ (forward)

5′‐CCTCGTAGATGGGCACAGT‐3′ (reverse)

BCL‐6

5′‐GGAGTCGAGACATCTTGACTGA‐3′ (forward)

5′‐ATGAGGACCGTTTTATGGGCT‐3′ (reverse)

BACH2

5′‐AATACCAGCTTGCATGTACCAA‐3′ (forward)

5′‐TTATCTTCCCGGAATGTGCTTG‐3′ (reverse)

GPER1

5′‐ CACCAGCAGTACGTGATCGG ‐3′ (forward)

5′‐ CATCTTCTCGCGGAAGCTGAT ‐3′ (reverse)

XBP1

5′‐ CCCTCCAGAACATCTCCCCAT ‐3′ (forward)

5′‐ ACATGACTGGGTCCAAGTTGT ‐3′ (reverse)

IRF4

5′‐ GCTGATCGACCAGATCGACAG ‐3′ (forward)

5′‐ CGGTTGTAGTCCTGCTTGC ‐3′ (reverse)

Oligonucleotide and primer sequence 5′‐TTCAACACCCCAGCCATG‐3′ (forward) 5′‐CCTCGTAGATGGGCACAGT‐3′ (reverse) 5′‐GGAGTCGAGACATCTTGACTGA‐3′ (forward) 5′‐ATGAGGACCGTTTTATGGGCT‐3′ (reverse) 5′‐AATACCAGCTTGCATGTACCAA‐3′ (forward) 5′‐TTATCTTCCCGGAATGTGCTTG‐3′ (reverse) 5′‐ CACCAGCAGTACGTGATCGG ‐3′ (forward) 5′‐ CATCTTCTCGCGGAAGCTGAT ‐3′ (reverse) 5′‐ CCCTCCAGAACATCTCCCCAT ‐3′ (forward) 5′‐ ACATGACTGGGTCCAAGTTGT ‐3′ (reverse) 5′‐ GCTGATCGACCAGATCGACAG ‐3′ (forward) 5′‐ CGGTTGTAGTCCTGCTTGC ‐3′ (reverse)

Hormone assays

Serum E2 was measured by electro‐chemiluminescence immunoassay (ECLIA, Cobas Roche Diagnostics). Intra‐ and inter‐assay variations were less than 8% and 11%, respectively.

Network construction, and gene oncology (GO) analysis, pathway analysis

String (https://string‐db.org/), a powerful tool aiming to construct a comprehensive and objective global network, it contains direct (physical) as well as indirect (functional) interactions. GeneMANIA (http://genemania.org/) is a user‐friendly web interface used for analysing gene functions, generating gene lists and prioritizing genes for functional assays. After selecting homo sapiens from the nine optional organisms, and entering the genes of interest into the search bar, the results showed. Potential targets were uploaded to the Metascape server (http://metascape.org/) for GO analysis, which was used to identify functionally related genes from the list of differentially expressed genes. Functionally related genes were usually categorized to biological processes, cellular components and molecular functions. A false discovery rate<5.0 and P value <.05 were considered statistically significant.

Statistical analysis

GraphPad Prism version 7.00 and SPSS version 21.0 software were used for statistical analysis. All data were presented as the mean ± SD. Variables between groups were analysed using the independent‐samples Student's t test or chi‐squared tests, and P < .05 was considered statistically significant.

RESULTS

The proportions of Tfh and B cells in PBMCs was positively related to the serum E2 level

To investigate the correlation between the proportions of Tfh and B cells, and the serum E2 level in human beings, we first analysed these parameters in the blood of women who underwent IVF treatment. Tfh cells were identified as CD4+CXCR5+PD‐1+, whereas B cells were defined as CD19+. As expected, serum E2 levels were higher in COH, ET, P groups compared with MP group (Supplemental Figure [Link], [Link]; P = .0009, P = .0039 and <.0001, respectively). Meanwhile, as shown in Figure 1A,B, the percentage of CD4+ T cells was significantly elevated in the COH and P groups compared with that in the MP group (P = .0388 and P = .0020, respectively). We also investigated the correlation between Tfh cell percentages and serum E2 levels in the MP and COH groups without progesterone interference, the result showed a positive relationship (Figure 1C; r 2 = .4398, p < .0001, n = 39). Relationship between B cell percentages and serum E2 levels showed a linear relationship (Supplemental Figure [Link], [Link]; r 2 = .1306, P = .0147, n = 39).
FIGURE 1

Percentages of T follicular helper (Tfh) cells are positive related to serum estradiol (E2) level in in vitro fertilization (IVF) patients. A, Percentages of Tfh cells in live CD4+ T cells. B, Percentages of Tfh cells are higher in controlled ovarian hyperstimulation (COH) and pregnant after embryo transfer (P) groups than menstrual period (MP) group (*P = .0388 and **P = .0020, respectively). No difference between the COH and P groups (P = .2342). C, Positive correlation between the percentages of Tfh cells in PBMCs and serum E2 level in MP and COH groups (r 2 = .4398, ****P < .0001, n = 39)

Percentages of T follicular helper (Tfh) cells are positive related to serum estradiol (E2) level in in vitro fertilization (IVF) patients. A, Percentages of Tfh cells in live CD4+ T cells. B, Percentages of Tfh cells are higher in controlled ovarian hyperstimulation (COH) and pregnant after embryo transfer (P) groups than menstrual period (MP) group (*P = .0388 and **P = .0020, respectively). No difference between the COH and P groups (P = .2342). C, Positive correlation between the percentages of Tfh cells in PBMCs and serum E2 level in MP and COH groups (r 2 = .4398, ****P < .0001, n = 39) As Tfh cells play crucial roles in the differentiation and maturation of B cells, we next examined changes in the B cell percentage in PBMCs. We found that the percentage of B cells was significantly increased in COH, ET and P groups compared with that in MP group (P = .0480, P = .0060 and P = .0038, respectively) (Figure 2A,B). Furthermore, the B cell percentage in PBMCs was positively correlated with the percentage of Tfh cells among CD4+ T cells (Figure 2C; r 2 = .2197, P = .0012, n = 39).
FIGURE 2

Percentages of B cells are positive related to Tfh cells in IVF patients. A, Percentages of B cells in live cells. B, Percentages of B cells are higher in COH, embryo transfer (ET) and P groups than MP group (*P = .0480, **P = .0060 and **P = .0038, respectively). C, Positive correlation between the percentage of B cells in PBMCs and serum E2 level in MP and COH groups (r 2 = .2197, **P < .0012, n = 39)

Percentages of B cells are positive related to Tfh cells in IVF patients. A, Percentages of B cells in live cells. B, Percentages of B cells are higher in COH, embryo transfer (ET) and P groups than MP group (*P = .0480, **P = .0060 and **P = .0038, respectively). C, Positive correlation between the percentage of B cells in PBMCs and serum E2 level in MP and COH groups (r 2 = .2197, **P < .0012, n = 39)

E2 promoted Tfh differentiation and enhanced plasma cell production

To clarify whether E2 increased the percentage of Tfh cells by enhancing their differentiation, we separated naïve CD4+ T cells from CBMCs and treated them with various concentrations of E2 under CD3/CD28 stimulation and conditions suitable for Tfh cell differentiation (TGF‐β1, IL‐23, IL‐6 co‐culture) in vitro. After a 6‐day culture, flow cytometry confirmed that the percentage of Tfh cells was significantly augmented after treatment with 20 µM E2 (Figure 3).
FIGURE 3

17β‐Estradiol induces Tfh cells differentiation in vitro. A, The flow cytometry analysis showed that 17β‐estradiol‐induced Tfh cells in a concentration‐dependent manner. B, Qualification of Tfh cells in total CBMC

17β‐Estradiol induces Tfh cells differentiation in vitro. A, The flow cytometry analysis showed that 17β‐estradiol‐induced Tfh cells in a concentration‐dependent manner. B, Qualification of Tfh cells in total CBMC Next, bioinformatics was used to clarify the potential mechanism underlying these interactions. We inputted BCL6, PD‐1, CXCR5, BACH2, PAX5, EBF, BLIMP1, E2A, OCT2, IRF4, XBP1, IL‐6, IL‐21, Erα, Erβ and G protein‐coupled oestrogen receptor (GPER) into STRING to establish protein‐protein interaction networks and perform a functional enrichment analysis (Figure 4A). GeneMANIA revealed interacting proteins that were functionally similar to these 16 genes; 49.8% were predicted, 40.8% had matching co‐expression characteristics and 6.13% displayed similar physical interactions (Figure 4B). To access probable signalling mechanisms, an analysis of the interaction networks using Metascape showed that 93.4% of the genes were enriched. The top three enriched pathways were regulation of T cell activation (GO:0050863), regulation of inflammatory response (GO:0050727), and positive regulation of the cytokine biosynthetic process (GO:0042108) (Figure 4C); these were dominantly enriched for GPER‐1, IL‐6, IL‐21, BCL6, CXCR5, PD‐1, IRF4 and XBP‐1.
FIGURE 4

Bioinformatic analysis of Tfh and B cell biomarkers. A, Protein‐protein interaction networks of cytokines, and Tfh and B cell transcription factors. B, Biomarker networks of Tfh and B cells. Black protein nodes indicate target proteins. Different connecting colours represent different correlations. The functional association of targets was analysed using GeneMANIA. Genes in black circles were submitted as query terms in searches. Grey circles indicate genes associated with query genes. C, Gene Ontology analysis of targets. The y‐axis shows significantly enriched Biological Process categories of the targets, and the x‐axis shows the enrichment scores of these terms (*P < .05)

Bioinformatic analysis of Tfh and B cell biomarkers. A, Protein‐protein interaction networks of cytokines, and Tfh and B cell transcription factors. B, Biomarker networks of Tfh and B cells. Black protein nodes indicate target proteins. Different connecting colours represent different correlations. The functional association of targets was analysed using GeneMANIA. Genes in black circles were submitted as query terms in searches. Grey circles indicate genes associated with query genes. C, Gene Ontology analysis of targets. The y‐axis shows significantly enriched Biological Process categories of the targets, and the x‐axis shows the enrichment scores of these terms (*P < .05)

Serum IL‐6 and IL‐21 levels correlated with the E2 level

IL‐21 and IL‐6 are not only secreted by Tfh cells, but also promote Tfh cell differentiation. Therefore, we measured the levels of IL‐21 and IL‐6 in serum using ELISAs (Figure 5A,C) and analysed the correlation between IL‐21, IL‐6 and E2 levels (Figure 5B,D). Our data demonstrated that under endogenous E2 treatment alone (the MP and COH groups, n = 39), without progesterone interference, both IL‐21 and IL‐6 levels were up‐regulated significantly in serum (P = .0041 and P = .0093, respectively); however, IL‐21 levels had no linear correlation with E2 levels.
FIGURE 5

Serum IL‐21 / IL‐6 levels, and relative expression of BCL‐6 / BACH2 in PBMC are higher in COH, ET and P groups than MP group. Serum IL‐21 and IL‐6 levels are positive correlated with serum E2 level. A, Serum IL‐21 levels is higher in COH, ET and P groups than MP group (**P = .0041, *P = .0484, and ***P = .0004, respectively). B, Positive correlation between serum IL‐21 and E2 levels in MP and COH groups (r 2 = .05234, P = .1306, n = 45). C, Serum IL‐6 levels is higher in COH, ET and P groups than MP group (**P = .0093, *P = .0426, and****p < .0001, respectively). D, Positive correlation between serum IL‐6 and E2 levels in MP and COH groups (r 2 = .1306, *P = .0147, n = 45). E, Relative expression of BCL‐6 in PBMCs is higher in COH, ET and P groups than MP group (***P = .0001, **P = .0030, and **P = .0053, respectively). F, Relative expression of BACH2 in PBMCs is higher in COH, ET and P groups than MP group (**P = .0075, **P = .0016, and *P = .0231, respectively)

Serum IL‐21 / IL‐6 levels, and relative expression of BCL‐6 / BACH2 in PBMC are higher in COH, ET and P groups than MP group. Serum IL‐21 and IL‐6 levels are positive correlated with serum E2 level. A, Serum IL‐21 levels is higher in COH, ET and P groups than MP group (**P = .0041, *P = .0484, and ***P = .0004, respectively). B, Positive correlation between serum IL‐21 and E2 levels in MP and COH groups (r 2 = .05234, P = .1306, n = 45). C, Serum IL‐6 levels is higher in COH, ET and P groups than MP group (**P = .0093, *P = .0426, and****p < .0001, respectively). D, Positive correlation between serum IL‐6 and E2 levels in MP and COH groups (r 2 = .1306, *P = .0147, n = 45). E, Relative expression of BCL‐6 in PBMCs is higher in COH, ET and P groups than MP group (***P = .0001, **P = .0030, and **P = .0053, respectively). F, Relative expression of BACH2 in PBMCs is higher in COH, ET and P groups than MP group (**P = .0075, **P = .0016, and *P = .0231, respectively)

E2 increased Tfh and B cell transcription factor expression

Besides IL‐6, IL‐21 and BCL6 (known markers of Tfh cells), recent studies identified BACH2 as a key transcription factor in antibody class switching. , The function of BACH2 in Tfh cells is still controversial. Thus, we detected its expression and that of BCL6 and BACH2 in vivo (Figure 5E,F). The expression of BACH2 was in accordance with that of IL‐21 and IL‐6. As a crucial transcription factor of plasma cells, the expression of XBP1 increased consistently with E2 levels, which further verified the relationship between E2 and B cells. Meanwhile, expression of IRF4 and GPER1 were consistent with the bioinformatics analysis, both in vivo and in vitro, indicating that IRF4 and GPER1 expression in Tfh and B cells were crucial for their augmentation (Figure 6).
FIGURE 6

Relative expression of XBP‐1, IRF‐4, and GPER‐1 in PBMC are higher in COH, ET and P groups than MP group. Relative expression of XBP‐1, IRF‐4, and GPER‐1 in Tfh cells differentiation system are higher with 17β‐Estradiol. A, Relative expression of XBP‐1 in PBMCs is higher in COH, ET and P groups than MP group (*P = .0406, ****P < .0001, and *P = .0177, respectively). B, Relative expression of IRF‐4 in PBMCs is higher in P groups than MP group (***P = .0009). C, Relative expression of GPER‐1 in PBMCs is higher in COH, ET and P groups than MP group (**P = .0062, ****P < .0001, and ****P < .0001, respectively). D, Relative expression of XBP‐1 in Tfh cells differentiation condition in vitro with various E2 concentrations (0 vs 10 μM, **P =.0011; 0 vs 20 μM, *P =.0135). E, Relative expression of IRF‐4 in Tfh cells differentiation condition in vitro with various E2 concentrations (0 vs 10 μM, P = .3969; 0 vs 20 μM, P = .0828; 10 vs 20 μM, P = .0518). F, Relative expression of GPER‐1 in Tfh cells differentiation condition in vitro with various E2 concentration (0 vs 10 μM, P = .5388; 0 vs 20 μM, *P = .0114; 10 vs 20 μM, **P = .0059)

Relative expression of XBP‐1, IRF‐4, and GPER‐1 in PBMC are higher in COH, ET and P groups than MP group. Relative expression of XBP‐1, IRF‐4, and GPER‐1 in Tfh cells differentiation system are higher with 17β‐Estradiol. A, Relative expression of XBP‐1 in PBMCs is higher in COH, ET and P groups than MP group (*P = .0406, ****P < .0001, and *P = .0177, respectively). B, Relative expression of IRF‐4 in PBMCs is higher in P groups than MP group (***P = .0009). C, Relative expression of GPER‐1 in PBMCs is higher in COH, ET and P groups than MP group (**P = .0062, ****P < .0001, and ****P < .0001, respectively). D, Relative expression of XBP‐1 in Tfh cells differentiation condition in vitro with various E2 concentrations (0 vs 10 μM, **P =.0011; 0 vs 20 μM, *P =.0135). E, Relative expression of IRF‐4 in Tfh cells differentiation condition in vitro with various E2 concentrations (0 vs 10 μM, P = .3969; 0 vs 20 μM, P = .0828; 10 vs 20 μM, P = .0518). F, Relative expression of GPER‐1 in Tfh cells differentiation condition in vitro with various E2 concentration (0 vs 10 μM, P = .5388; 0 vs 20 μM, *P = .0114; 10 vs 20 μM, **P = .0059)

DISCUSSION

In this study, we revealed a positive correlation between the numbers of Tfh and B cells, and E2 levels, during IVF. Combined with in vitro Tfh differentiation and a bioinformatics analysis, we speculated that E2 may affect Tfh cell numbers and favour humoural immunity through GPER1 and transcription factors, including BCL6, BACH2, XBP1 and IRF4. This indicated that the regulation of Tfh cells might be a novel target to modulate the maternal‐foetal immune balance. E2 generally works through its receptor, which is widely expressed on the surface and intracellular of various cells. High E2 levels in the serum may indicate enhanced pro‐inflammatory T cells, such as Th1 and Th17 subsets, instead of protective Th2 and T regulatory subgroups. , Oestrogen receptors (ERs) can be divided into three major subsets: nuclear receptor ERα, ERβ, and GPER. , BCL6, PD‐1, CXCR5 and BACH2 are functional genes for Tfh cells, while IL‐6 and IL‐21 are the released cytokines. PAX5, EBF, BLIMP1, E2A, OCT2, IRF4 and XBP1 might be crucial transcription factors involved in different stages of B cell differentiation. Meanwhile, E2 plays a dichotomous role in augmenting myeloid‐derived suppressor cells while inhibiting T cell functions. Furthermore, IL‐6 is commonly secreted by different subgroups of activated T cells, as well as others such as myeloid‐derived suppressor cells. Our data demonstrated that under endogenous E2 treatment alone, without progesterone interference, both IL‐21 and IL‐6 levels were up‐regulated significantly in serum; however, IL‐21 levels had no linear correlation with E2 levels. This finding might be because, during pregnancy and supraphysiological E2 stimulation, cell subsets change and the complex microenvironment might contribute to higher IL‐6 concentrations. Here, we proposed that E2 might play a dominant role in Tfh cell recruitment and differentiation. We defined Tfh cells as CD4+CXCR5+PD‐1+. It is well‐established that IL‐6 is a potent inducer of IL‐21, which has been observed in activated murine CD4+ T cells. IL‐6 also drives CXCR5 expression and induces transient BCL6 expression. IL‐6 deficiency results in the severe reduction of CXCR5+BCL6+ early Tfh cells in vivo within 72 hours of an acute viral infection. In some diseases, PD‐1+ Tfh cells are considered better B cell activators than the PD‐1‐ subset. Both the Tfh and B cell percentages were elevated in the COH group, with no significant difference compared with those in the P group. Although the percentages of Tfh and B cells in the ET group were notably higher than those in the MP group, they were slightly lower than those in the COH group. This indicates that E2 might play a crucial role in augmenting Tfh and B cells during pregnancy, independent of progesterone. Furthermore, after inducing Tfh cells in vitro, they exhibited enhanced differentiation upon E2 treatment, as expected. BACH2, another important transcription factor to maintain the phenotype of GC B cells, is also expressed by T cells and directs their differentiation, homeostasis and effector functions. , BACH2 is highly expressed in GC B cells and is required for antibody class switching and blocking plasma cell differentiation. In addition, BACH2‐mediated regulation can suppress the CXCR5 promoter via the site 1 negative regulatory element during Tfh cell differentiation. Strikingly, in contrast to GC B cells, Tfh cells are characterized by low expression of BACH2 in mice. BACH2 overexpression in Tfh cells inhibits a specific set of genes, including IL‐21 and BCL6, indicating that the function of this transcription factor is reversed in T cells. Previous studies suggested that BACH2 is associated with numerous autoimmune and allergic diseases in humans by inducing excessive pathogenic Tfh cells, which is opposite to results observed in mice. Little is known about the contrasting effects of BACH2 in mice and humans; therefore, further research is needed. Both IRF4 and XBP1 play important roles in plasma B cell differentiation, immunoglobulin secretion and isotype switching. , IRF4 has been confirmed as a crucial transcription factor in Tfh cell differentiation. Our bioinformatics analysis showed that the ER, Tfh and B cell transcription factors, IRF4 and XBP1, were enriched. Hence, our results demonstrated that, upon E2 exposure, a forward loop was formed in which GPER1 was activated to increase BCL6, BACH2, XBP1 and IRF4 expression, thereby driving Tfh and plasma cell augmentation. Numerous mouse studies have supported the vital role of Tfh cells in autoimmune diseases. , , In addition, increased E2 and Tfh cell levels have been observed frequently in human autoimmune diseases, such as systemic lupus erythematosus, and are positively correlated with serum autoantibody titres and disease severity. , This suggests an important role of E2 and Tfh cells in the pathogenesis of these diseases.

CONCLUSIONS

We demonstrated that Tfh cells, as a novel subset of immune cells involved in immune tolerance at the maternal‐foetal interface, are influenced by circulating E2 levels. Tfh cells also regulate cytokines and transcription factors, contributing to enhanced humoural immunity. Further investigation of these important results will advance our understanding of the clinical application of Tfh cells as a therapeutic target for immune‐related miscarriage and IVF failure.

ETHICS STATEMENT

The Ethics Review Boards of the First Hospital of Jilin University (No. 2018‐069) and the Jilin Province People's Hospital (No.2018‐Y‐005) approved this research. Study participants and/or their legal guardians provided written informed consent.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

AUTHOR CONTRIBUTION

Cong Hu: Data curation (lead); Formal analysis (lead); Writing‐original draft (lead). Honglei Liu: Data curation (equal); Formal analysis (equal); Writing‐original draft (equal). Bo Pang: Data curation (equal); Methodology (equal); Software (lead); Visualization (lead). Hao Wu: Investigation (equal); Resources (equal); Visualization (equal). Xiuying Lin: Resources (lead). Yu Zhen: Conceptualization (equal); Project administration (equal); Resources (equal). Huanfa Yi: Conceptualization (lead); Project administration (lead); Supervision (lead); Writing‐review & editing (lead). FigS1‐Legends Click here for additional data file. FigS1 Click here for additional data file. TableS1 Click here for additional data file.
  55 in total

1.  Plasma cell differentiation requires the transcription factor XBP-1.

Authors:  A M Reimold; N N Iwakoshi; J Manis; P Vallabhajosyula; E Szomolanyi-Tsuda; E M Gravallese; D Friend; M J Grusby; F Alt; L H Glimcher
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  An investigation of the relationship between recurrent spontaneous abortion and memory T follicular helper cells.

Authors:  Xiaorui Luan; Xiaomin Kang; Weiping Li; Qian Dong
Journal:  Am J Reprod Immunol       Date:  2017-06-21       Impact factor: 3.886

3.  Bach2 Negatively Regulates T Follicular Helper Cell Differentiation and Is Critical for CD4+ T Cell Memory.

Authors:  Jianlin Geng; Hairong Wei; Bi Shi; Yin-Hu Wang; Braxton D Greer; Melanie Pittman; Emily Smith; Paul G Thomas; Olaf Kutsch; Hui Hu
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

4.  Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.

Authors:  Jin-Young Choi; John Hsi-en Ho; Sandra G Pasoto; Viviane Bunin; Sang Taek Kim; Solange Carrasco; Eduardo F Borba; Celio R Gonçalves; Priscila R Costa; Esper G Kallas; Eloisa Bonfa; Joseph Craft
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

5.  Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation.

Authors:  Youn Soo Choi; Danelle Eto; Jessica A Yang; Christopher Lao; Shane Crotty
Journal:  J Immunol       Date:  2013-02-27       Impact factor: 5.422

6.  Bcl6 mediates the development of T follicular helper cells.

Authors:  Roza I Nurieva; Yeonseok Chung; Gustavo J Martinez; Xuexian O Yang; Shinya Tanaka; Tatyana D Matskevitch; Yi-Hong Wang; Chen Dong
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

Review 7.  Regulators of Tfh Cell Differentiation.

Authors:  Gajendra M Jogdand; Suchitra Mohanty; Satish Devadas
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

8.  Estrogen receptor α in T cells suppresses follicular helper T cell responses and prevents autoimmunity.

Authors:  Do-Hyun Kim; Hong-Jai Park; Hyeon-Soo Park; Jae-Ung Lee; CheMyong Ko; Myung Chan Gye; Je-Min Choi
Journal:  Exp Mol Med       Date:  2019-04-15       Impact factor: 8.718

9.  Myeloid-Derived Suppressor Cells Are Regulated by Estradiol and Are a Predictive Marker for IVF Outcome.

Authors:  Cong Hu; Yu Zhen; Bo Pang; Xiuying Lin; Huanfa Yi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-30       Impact factor: 5.555

10.  BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.

Authors:  Rahul Roychoudhuri; Kiyoshi Hirahara; Kambiz Mousavi; David Clever; Christopher A Klebanoff; Michael Bonelli; Giuseppe Sciumè; Hossein Zare; Golnaz Vahedi; Barbara Dema; Zhiya Yu; Hui Liu; Hayato Takahashi; Mahadev Rao; Pawel Muranski; Joseph G Crompton; George Punkosdy; Davide Bedognetti; Ena Wang; Victoria Hoffmann; Juan Rivera; Francesco M Marincola; Atsushi Nakamura; Vittorio Sartorelli; Yuka Kanno; Luca Gattinoni; Akihiko Muto; Kazuhiko Igarashi; John J O'Shea; Nicholas P Restifo
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

View more
  1 in total

1.  Supraphysiological estradiol promotes human T follicular helper cell differentiation and favours humoural immunity during in vitro fertilization.

Authors:  Cong Hu; HongLei Liu; Bo Pang; Hao Wu; Xiuying Lin; Yu Zhen; Huanfa Yi
Journal:  J Cell Mol Med       Date:  2021-05-24       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.